Annual D&A
$2.90 M
+$10.00 K+0.35%
31 December 2023
Summary:
Heron Therapeutics annual depreciation & amortization is currently $2.90 million, with the most recent change of +$10.00 thousand (+0.35%) on 31 December 2023. During the last 3 years, it has risen by +$52.00 thousand (+1.83%). HRTX annual D&A is now -4.04% below its all-time high of $3.02 million, reached on 31 December 2021.HRTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$581.00 K
-$60.00 K-9.36%
30 September 2024
Summary:
Heron Therapeutics quarterly depreciation & amortization is currently $581.00 thousand, with the most recent change of -$60.00 thousand (-9.36%) on 30 September 2024. Over the past year, it has dropped by -$146.00 thousand (-20.08%). HRTX quarterly D&A is now -26.83% below its all-time high of $794.00 thousand, reached on 31 December 2021.HRTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$2.63 M
-$146.00 K-5.27%
30 September 2024
Summary:
Heron Therapeutics TTM depreciation & amortization is currently $2.63 million, with the most recent change of -$146.00 thousand (-5.27%) on 30 September 2024. Over the past year, it has dropped by -$349.00 thousand (-11.73%). HRTX TTM D&A is now -13.08% below its all-time high of $3.02 million, reached on 31 December 2021.HRTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +0.3% | -20.1% | -11.7% |
3 y3 years | +1.8% | -22.9% | -10.7% |
5 y5 years | +91.6% | +11.5% | +38.2% |
HRTX Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -4.0% | +1.8% | -26.8% | at low | -13.1% | at low |
5 y | 5 years | -4.0% | +91.6% | -26.8% | +11.5% | -13.1% | +38.2% |
alltime | all time | -4.0% | +1288.1% | -26.8% | +196.8% | -13.1% | +537.7% |
Heron Therapeutics Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $581.00 K(-9.4%) | $2.63 M(-5.3%) |
June 2024 | - | $641.00 K(-7.0%) | $2.77 M(-3.4%) |
Mar 2024 | - | $689.00 K(-3.6%) | $2.87 M(-1.0%) |
Dec 2023 | $2.90 M(+0.3%) | $715.00 K(-1.7%) | $2.90 M(-2.6%) |
Sept 2023 | - | $727.00 K(-1.6%) | $2.98 M(+0.7%) |
June 2023 | - | $739.00 K(+2.9%) | $2.95 M(+2.4%) |
Mar 2023 | - | $718.00 K(-9.2%) | $2.89 M(-0.1%) |
Dec 2022 | $2.89 M(-4.4%) | $791.00 K(+12.0%) | $2.89 M(-0.1%) |
Sept 2022 | - | $706.00 K(+5.2%) | $2.89 M(-1.6%) |
June 2022 | - | $671.00 K(-6.9%) | $2.94 M(-2.1%) |
Mar 2022 | - | $721.00 K(-9.2%) | $3.00 M(-0.6%) |
Dec 2021 | $3.02 M(+6.1%) | $794.00 K(+5.3%) | $3.02 M(+2.8%) |
Sept 2021 | - | $754.00 K(+2.7%) | $2.94 M(-0.5%) |
June 2021 | - | $734.00 K(-0.7%) | $2.95 M(-0.4%) |
Mar 2021 | - | $739.00 K(+3.8%) | $2.96 M(+4.1%) |
Dec 2020 | $2.85 M(+39.3%) | $712.00 K(-7.4%) | $2.85 M(+5.5%) |
Sept 2020 | - | $769.00 K(+3.2%) | $2.70 M(+10.1%) |
June 2020 | - | $745.00 K(+20.0%) | $2.45 M(+11.5%) |
Mar 2020 | - | $621.00 K(+10.1%) | $2.20 M(+7.5%) |
Dec 2019 | $2.04 M(+35.1%) | $564.00 K(+8.3%) | $2.04 M(+7.6%) |
Sept 2019 | - | $521.00 K(+5.9%) | $1.90 M(+7.9%) |
June 2019 | - | $492.00 K(+5.4%) | $1.76 M(+10.1%) |
Mar 2019 | - | $467.00 K(+11.2%) | $1.60 M(+5.7%) |
Dec 2018 | $1.51 M(-1.2%) | $420.00 K(+9.9%) | $1.51 M(+2.4%) |
Sept 2018 | - | $382.00 K(+15.8%) | $1.48 M(-1.5%) |
June 2018 | - | $330.00 K(-13.4%) | $1.50 M(-5.2%) |
Mar 2018 | - | $381.00 K(-1.0%) | $1.58 M(+3.4%) |
Dec 2017 | $1.53 M(+39.3%) | $385.00 K(-4.9%) | $1.53 M(+5.4%) |
Sept 2017 | - | $405.00 K(-1.7%) | $1.45 M(+7.5%) |
June 2017 | - | $412.00 K(+25.2%) | $1.35 M(+13.5%) |
Mar 2017 | - | $329.00 K(+7.5%) | $1.19 M(+8.3%) |
Dec 2016 | $1.10 M(+49.7%) | $306.00 K(+0.7%) | $1.10 M(+6.8%) |
Sept 2016 | - | $304.00 K(+21.1%) | $1.03 M(+14.3%) |
June 2016 | - | $251.00 K(+5.5%) | $900.00 K(+9.8%) |
Mar 2016 | - | $238.00 K(+0.8%) | $820.00 K(+11.7%) |
Dec 2015 | $734.00 K(+27.0%) | $236.00 K(+34.9%) | $734.00 K(+6.8%) |
Sept 2015 | - | $175.00 K(+2.3%) | $687.00 K(+3.8%) |
June 2015 | - | $171.00 K(+12.5%) | $662.00 K(+7.5%) |
Mar 2015 | - | $152.00 K(-19.6%) | $616.00 K(+6.6%) |
Dec 2014 | $578.00 K(+73.6%) | $189.00 K(+26.0%) | $578.00 K(+19.2%) |
Sept 2014 | - | $150.00 K(+20.0%) | $485.00 K(+14.7%) |
June 2014 | - | $125.00 K(+9.6%) | $423.00 K(+12.2%) |
Mar 2014 | - | $114.00 K(+18.8%) | $377.00 K(+13.2%) |
Dec 2013 | $333.00 K(+69.0%) | $96.00 K(+9.1%) | $333.00 K(+16.0%) |
Sept 2013 | - | $88.00 K(+11.4%) | $287.00 K(+13.9%) |
June 2013 | - | $79.00 K(+12.9%) | $252.00 K(+16.7%) |
Mar 2013 | - | $70.00 K(+40.0%) | $216.00 K(+9.6%) |
Dec 2012 | $197.00 K(+10.1%) | $50.00 K(-5.7%) | $197.00 K(+4.2%) |
Sept 2012 | - | $53.00 K(+23.3%) | $189.00 K(+5.6%) |
June 2012 | - | $43.00 K(-15.7%) | $179.00 K(-1.6%) |
Mar 2012 | - | $51.00 K(+21.4%) | $182.00 K(+1.7%) |
Dec 2011 | $179.00 K(-21.1%) | $42.00 K(-2.3%) | $179.00 K(-3.8%) |
Sept 2011 | - | $43.00 K(-6.5%) | $186.00 K(-6.1%) |
June 2011 | - | $46.00 K(-4.2%) | $198.00 K(-4.8%) |
Mar 2011 | - | $48.00 K(-2.0%) | $208.00 K(-8.4%) |
Dec 2010 | $227.00 K(-36.2%) | $49.00 K(-10.9%) | $227.00 K(-14.0%) |
Sept 2010 | - | $55.00 K(-1.8%) | $264.00 K(-11.1%) |
June 2010 | - | $56.00 K(-16.4%) | $297.00 K(-9.5%) |
Mar 2010 | - | $67.00 K(-22.1%) | $328.00 K(-7.9%) |
Dec 2009 | $356.00 K(-13.6%) | $86.00 K(-2.3%) | $356.00 K(-4.3%) |
Sept 2009 | - | $88.00 K(+1.1%) | $372.00 K(-4.6%) |
June 2009 | - | $87.00 K(-8.4%) | $390.00 K(-4.6%) |
Mar 2009 | - | $95.00 K(-6.9%) | $409.00 K(-0.7%) |
Dec 2008 | $412.00 K(+42.6%) | $102.00 K(-3.8%) | $412.00 K(+3.5%) |
Sept 2008 | - | $106.00 K(0.0%) | $398.00 K(-1426.7%) |
June 2008 | - | $106.00 K(+8.2%) | -$30.00 K(-109.6%) |
Mar 2008 | - | $98.00 K(+11.4%) | $314.00 K(+8.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2007 | $289.00 K(-218.4%) | $88.00 K(-127.3%) | $289.00 K(-190.3%) |
Sept 2007 | - | -$322.00 K(-171.6%) | -$320.00 K(-459.6%) |
June 2007 | - | $450.00 K(+516.4%) | $89.00 K(-133.2%) |
Mar 2007 | - | $73.00 K(-114.0%) | -$268.00 K(+9.8%) |
Dec 2006 | -$244.00 K(-154.7%) | -$521.00 K(-698.9%) | -$244.00 K(-142.4%) |
Sept 2006 | - | $87.00 K(-6.5%) | $575.00 K(+42.3%) |
June 2006 | - | $93.00 K(-4.1%) | $404.00 K(-6.9%) |
Mar 2006 | - | $97.00 K(-67.4%) | $434.00 K(-2.7%) |
Dec 2005 | $446.00 K(-29.2%) | $298.00 K(-454.8%) | $446.00 K(-20.4%) |
Sept 2005 | - | -$84.00 K(-168.3%) | $560.00 K(-22.0%) |
June 2005 | - | $123.00 K(+12.8%) | $718.00 K(+4.1%) |
Mar 2005 | - | $109.00 K(-73.5%) | $690.00 K(+9.5%) |
Dec 2004 | $630.00 K(-3.5%) | $412.00 K(+456.8%) | $630.00 K(+29.6%) |
Sept 2004 | - | $74.00 K(-22.1%) | $486.00 K(-13.5%) |
June 2004 | - | $95.00 K(+93.9%) | $562.00 K(-7.6%) |
Mar 2004 | - | $49.00 K(-81.7%) | $608.00 K(-6.9%) |
Dec 2003 | $653.00 K(+38.6%) | $268.00 K(+78.7%) | $653.00 K(+12.0%) |
Sept 2003 | - | $150.00 K(+6.4%) | $583.00 K(+32.8%) |
June 2003 | - | $141.00 K(+50.0%) | $439.00 K(-2.9%) |
Mar 2003 | - | $94.00 K(-52.5%) | $452.00 K(-4.0%) |
Dec 2002 | $471.00 K(-16.0%) | $198.00 K(+3200.0%) | $471.00 K(+72.5%) |
Sept 2002 | - | $6000.00(-96.1%) | $273.00 K(+2.2%) |
June 2002 | - | $154.00 K(+36.3%) | $267.00 K(+136.3%) |
Mar 2002 | - | $113.00 K(-43.5%) | $113.00 K(-43.5%) |
Dec 2001 | $561.00 K(+105.5%) | - | - |
Dec 2000 | $273.00 K(+36.5%) | - | - |
Dec 1999 | $200.00 K(+100.0%) | $200.00 K(-140.0%) | $200.00 K(-133.3%) |
Sept 1999 | - | -$500.00 K(-350.0%) | -$600.00 K(+500.0%) |
June 1999 | - | $200.00 K(-33.3%) | -$100.00 K(-200.0%) |
Mar 1999 | - | $300.00 K(-150.0%) | $100.00 K(0.0%) |
Dec 1998 | $100.00 K(-66.7%) | -$600.00 K(<-9900.0%) | $100.00 K(-66.7%) |
Sept 1998 | - | $0.00(-100.0%) | $300.00 K(-40.0%) |
June 1998 | - | $400.00 K(+33.3%) | $500.00 K(+66.7%) |
Mar 1998 | - | $300.00 K(-175.0%) | $300.00 K(0.0%) |
Dec 1997 | $300.00 K(-78.6%) | -$400.00 K(-300.0%) | $300.00 K(-62.5%) |
Sept 1997 | - | $200.00 K(0.0%) | $800.00 K(-27.3%) |
June 1997 | - | $200.00 K(-33.3%) | $1.10 M(-15.4%) |
Mar 1997 | - | $300.00 K(+200.0%) | $1.30 M(-7.1%) |
Dec 1996 | $1.40 M(+16.7%) | $100.00 K(-80.0%) | $1.40 M(-12.5%) |
Sept 1996 | - | $500.00 K(+25.0%) | $1.60 M(+14.3%) |
June 1996 | - | $400.00 K(0.0%) | $1.40 M(+7.7%) |
Mar 1996 | - | $400.00 K(+33.3%) | $1.30 M(+8.3%) |
Dec 1995 | $1.20 M(+9.1%) | $300.00 K(0.0%) | $1.20 M(-7.7%) |
Sept 1995 | - | $300.00 K(0.0%) | $1.30 M(+18.2%) |
June 1995 | - | $300.00 K(0.0%) | $1.10 M(0.0%) |
Mar 1995 | - | $300.00 K(-25.0%) | $1.10 M(0.0%) |
Dec 1994 | $1.10 M(-8.3%) | $400.00 K(+300.0%) | $1.10 M(0.0%) |
Sept 1994 | - | $100.00 K(-66.7%) | $1.10 M(-15.4%) |
June 1994 | - | $300.00 K(0.0%) | $1.30 M(0.0%) |
Mar 1994 | - | $300.00 K(-25.0%) | $1.30 M(+8.3%) |
Dec 1993 | $1.20 M(+9.1%) | $400.00 K(+33.3%) | $1.20 M(+9.1%) |
Sept 1993 | - | $300.00 K(0.0%) | $1.10 M(0.0%) |
June 1993 | - | $300.00 K(+50.0%) | $1.10 M(0.0%) |
Mar 1993 | - | $200.00 K(-33.3%) | $1.10 M(0.0%) |
Dec 1992 | $1.10 M(+37.5%) | $300.00 K(0.0%) | $1.10 M(+10.0%) |
Sept 1992 | - | $300.00 K(0.0%) | $1.00 M(+11.1%) |
June 1992 | - | $300.00 K(+50.0%) | $900.00 K(+12.5%) |
Mar 1992 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
Dec 1991 | $800.00 K(0.0%) | $200.00 K(0.0%) | $800.00 K(0.0%) |
Sept 1991 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
June 1991 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
Mar 1991 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
Dec 1990 | $800.00 K(+14.3%) | $200.00 K(0.0%) | $800.00 K(+33.3%) |
Sept 1990 | - | $200.00 K(0.0%) | $600.00 K(+50.0%) |
June 1990 | - | $200.00 K(0.0%) | $400.00 K(+100.0%) |
Mar 1990 | - | $200.00 K | $200.00 K |
Dec 1989 | $700.00 K | - | - |
FAQ
- What is Heron Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Heron Therapeutics?
- What is Heron Therapeutics annual D&A year-on-year change?
- What is Heron Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Heron Therapeutics?
- What is Heron Therapeutics quarterly D&A year-on-year change?
- What is Heron Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Heron Therapeutics?
- What is Heron Therapeutics TTM D&A year-on-year change?
What is Heron Therapeutics annual depreciation & amortization?
The current annual D&A of HRTX is $2.90 M
What is the all time high annual D&A for Heron Therapeutics?
Heron Therapeutics all-time high annual depreciation & amortization is $3.02 M
What is Heron Therapeutics annual D&A year-on-year change?
Over the past year, HRTX annual depreciation & amortization has changed by +$10.00 K (+0.35%)
What is Heron Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of HRTX is $581.00 K
What is the all time high quarterly D&A for Heron Therapeutics?
Heron Therapeutics all-time high quarterly depreciation & amortization is $794.00 K
What is Heron Therapeutics quarterly D&A year-on-year change?
Over the past year, HRTX quarterly depreciation & amortization has changed by -$146.00 K (-20.08%)
What is Heron Therapeutics TTM depreciation & amortization?
The current TTM D&A of HRTX is $2.63 M
What is the all time high TTM D&A for Heron Therapeutics?
Heron Therapeutics all-time high TTM depreciation & amortization is $3.02 M
What is Heron Therapeutics TTM D&A year-on-year change?
Over the past year, HRTX TTM depreciation & amortization has changed by -$349.00 K (-11.73%)